Responsible for leading a healthcare Service design team focused on the delivery of Digital Health programmes in partnership with healthcare & tech. With the aim of transforming clinical pathway, improving outcomes for patients and enabling new ways to contract. Programmes are based on prioritized use-cases sponsored by the senior executive team at AZ and focused on Respiratory, cardiovascular, metabolic and Renal diseases. The aim is to enable personalised health and ensure patients get the right care at the right time. (Typically involves risk stratification, pathway redesign, SOP development, EMR integration and the deployment of monitoring technology and telemedicine MDT)Programmes include x2 US health system partnerships and a significant partnership with the Imperial college London all focused on the delivery of new disease management long term condition remote care pathways. Mass General Brigham: Heart Failure disease management (remote monitoring programme at discharge, integrated into EPIC aimed at reducing 30 readmission). Austin Allergy Clinic: Asthma disease management programme (aimed at avoiding disease deterioration and acting quicker). Imperial DiscoverNOW partnership. AZ have provided 3 FTEs for 18 months to support the North west London ICS to design, create and deploy new "sustainable" remote care pathways aimed at improving care for Type 2 diabetic patients and heart failure patients. Involves use of de-identified health data used to baseline clinical practice and re evaluate new pathways. Extensive pathway redesign, SOP development, training and roll out of new technology. Creation of RWE protocols and payer business cases to ensure scale.

Leads a multi-functional team of marketing and digital experts focused on developing innovative digital solutions addressing AstraZeneca’s commercial and clinical global business issues. Determines if digital solutions should be developed bespoke, through collaborations with start-up companies, device manufacturers, or other technology companies. Leads business transformation process for integrating and scaling digital innovation back into AstraZeneca’s functional areas and across global markets.Key Achievements- Launched a digital health partnership with a major US cancer institute aimed at digitalising care plans , improving survivor-ship care and enhancing communications between academic and community based oncology care givers- Leading a team of developers with an immuno-oncology patient service which aims to establish confidence in community oncologists by actively supporting patients through their IO infusions and sharing experiences/side effects with care givers.- Scaled innovative digital coaching adherence program in conjunction with Duke Clinical Research Institute (DCRI) and start-up, Vida Health, to drive behaviour change in patients across AstraZeneca’s core therapeutic areas – Cardiovascular, Oncology, and Respiratory. The research paper was presented at the 2016 AHA conference.- Developed digital clinical trials platform geared toward creating patient- facing materials in-house via a bespoke CMS that will enable faster recruiting and greater retention of patients in all phases of clinical trials. Being used by over 10 clinical trials and now transitioning as a business as usual innovation across the AZ clinical organisation.- Integrated an AZ mobile application designed to create greater scientific exchange among physicians at medical conferences. The application holds a patent and has been integrated into the core events app of an events start-up company which works with major medical congresses globally.

Responsible for leading the development of digital innovations in both clinical and commercial settings.Key successes- Development of a new communication approach between sales and marketing colleagues in the Japanese marketing company. Involved: deep ethnographic research into the cultures, processes and technologies adopted in the Japan affiliate. Resulted in significant business process change and the adoption of social dashboards and voice sentiment insight capture from the sales force.- Start up partnership with a unique and ground breaking remote GP service in the UK to support the improved self management of COPD patients.

Responsible for owning and driving the commercial excellence plan across Russia, Asia Region and Australia.Responsibilities involved:- Building the marketing and sales capability plan and delivery (Marketing excellence, Sales excellence and KAM) for highlighted regions.- Maintaining and developing the different multi channel approaches across therapy areas.- Driving marketing capability enhancements with the introduction of new digital solutions and practices.- Reporting back to regional and global brand VPs

Accountable for the Business Engagement and Alignment to the New Global Sales Channels processes in AstraZeneca.Responsible for the development of strategy and future thinking in terms of multi channel marketing and new selling processes.Actively involved in business transformation, as well as challenging the resource management across the product portfolio in 17 key AstraZeneca markets.Focused on Salesforce, Call center, Innovative rep channels and Digital

I work for the central SFE department at AZ. I am fully aligned to the CRM programme we are rolling out globally. I am currently responsible for the implementation and ongoing success of 14 marketing affiliates based in central and eastern europe, Greece, Turkey, portugal and Austria.My key roll is to be the brideg between the business and the technical deployment of the application. I work with Accenture during build, Cognizant for Service and IBM for platform services.

I help to manage the deployment and training of a global CRM system. The system incorporates all parts of the company helping to improve cross-functional working. It also helps to provide a complete view of the customer. (Sales, Marketing, Cliniacl and Medical Information). The software we are deploying is Siebel 7.7.

Responsible for the sales of a Cadiovascular product and GI product in the north west of England. Activities included Presenting, organising large meetings. Networking and relationship building was also paramount in the success of this role.

For 4.5 months of the pandemic I was officially seconded to NHSx to lead the deployment of virtual wards across 5 NWL primary care CCGs and one secondary care hospital in north west london. I led a team (AZImperial design team) to set up and deploy remote monitoring and new COVID 19 virtual ward pathways in 4 weeks (Inc pathway, process mapping, EPR templates, SOPs, technology, IG, training and measurement). Over 300+ patients monitored (Huma app) and significant evidence generated to show safety, acceptability, resource efficiency and improved outcomes due to early action based on disease deterioration. Preliminary results published by NHSx and NHSE. "Virtual wards" have now been scaled across the UK. Methodology and framework created has been codified and scaled within NHSx and local AHSNs.